Anti-Wnt3 and Wnt3a antibody [EPR4920(2)]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(27 Publications)
Rabbit Recombinant Monoclonal WNT3A antibody. Suitable for WB and reacts with Transfected cell lysate - Human samples. Cited in 27 publications.
View Alternative Names
Protein Wnt-3a, WNT3A
- WB
Supplier Data
Western blot - Anti-Wnt3 and Wnt3a antibody [EPR4920(2)] (AB172612)
All lanes:
Western blot - Anti-Wnt3 and Wnt3a antibody [EPR4920(2)] (ab172612) at 1/10000 dilution
Lane 1:
CHO cell lysate, non-transfected at 10 µg
Lane 2:
CHO cell lysate, transfected with Human Wnt3a at 10 µg
Predicted band size: 39 kDa
false
Related conjugates and formulations (1)
-
Anti-Wnt3 and Wnt3a antibody [EPR4920(2)] - BSA and Azide free
Reactivity data
Product details
This antibody was developed as part of a collaboration with Karl Willert's lab from the University of California at San Diego.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Wnt3 and Wnt3a are key players in cell proliferation differentiation and migration. These proteins are part of the Wnt signaling complex which influences gene expression important for embryonic development and tissue homeostasis. The Wnt3 and Wnt3a promote stem cell maintenance and expansion by regulating transcriptional activators and repressors. Their role extends to maintaining cellular architecture through interaction with cytoskeletal elements.
Pathways
Wnt3 and Wnt3a are integral components of the canonical Wnt/β-catenin pathway and the Wnt/Ca2+ non-canonical pathway. Through these pathways they impact various biological processes essential to cellular growth and differentiation. Wnt3a often interacts with β-catenin a well-known mediator that influences gene expression by entering the nucleus. Both Wnts regulate pathways that include Dishevelled (Dvl) proteins highlighting their interconnectedness in cell signaling networks.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (27)
Recent publications for all applications. Explore the full list and refine your search
Journal of cellular and molecular medicine 29:e70499 PubMed40099939
2025
Applications
Unspecified application
Species
Unspecified reactive species
Gut microbes 16:2347722 PubMed38706205
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell cycle (Georgetown, Tex.) 22:1544-1562 PubMed37287276
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of gastroenterology 58:444-457 PubMed36739585
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 40:111293 PubMed36044854
2022
Applications
Unspecified application
Species
Unspecified reactive species
Environmental toxicology 37:2540-2551 PubMed35841383
2022
Applications
Unspecified application
Species
Unspecified reactive species
ESC heart failure 8:3935-3946 PubMed34165260
2021
Applications
Unspecified application
Species
Unspecified reactive species
Aging 13:262-278 PubMed33436530
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 25:1958-1971 PubMed33434361
2021
Applications
Unspecified application
Species
Unspecified reactive species
Evidence-based complementary and alternative medic 2020:3025946 PubMed33082821
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com